Common disease with tratment
Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
I have enough content from the medical library to give a comprehensive, well-structured answer. Here is an overview of the most common diseases and their treatments, drawn from authoritative medical textbooks:
Common Diseases and Their Treatments
1. 🫀 Hypertension (High Blood Pressure)
Definition: Sustained BP ≥ 130/80 mmHg (US guidelines) or ≥ 140/90 mmHg (European guidelines).
Treatment:
Current US and European guidelines are now closely aligned:
| Step | Drug Choice |
|---|---|
| First-line | ACE inhibitor (e.g., enalapril) OR ARB (e.g., losartan) |
| Add-on | Calcium Channel Blocker (CCB, e.g., amlodipine) |
| Add-on | Thiazide/thiazide-like diuretic (e.g., chlorthalidone) |
| Triple therapy | RAS blocker + CCB + thiazide |
| Resistant HTN | Add spironolactone |
| Special indications | β-blockers for angina, heart failure with reduced EF, or AF rate control |
Key principle: Most patients with BP ≥ 140/90 mmHg should START on two-drug combination therapy. Single-pill combinations improve adherence.
(Comprehensive Clinical Nephrology, 7th Ed.)
2. 🩸 Diabetes Mellitus (Type 2)
Goals: HbA1c < 7%, fasting glucose 90–130 mg/dL.
Treatment Ladder:
| Drug Class | Example | Mechanism |
|---|---|---|
| Biguanides (first-line) | Metformin | ↓ hepatic glucose output; does not cause weight gain or hypoglycemia |
| Sulfonylureas | Glipizide, Glimepiride | ↑ pancreatic insulin secretion |
| Thiazolidinediones | Pioglitazone | ↑ insulin sensitivity |
| DPP-4 Inhibitors | Sitagliptin | ↓ insulin degradation |
| GLP-1 Agonists | Liraglutide, Semaglutide | ↑ insulin secretion, ↓ appetite |
| SGLT-2 Inhibitors | Empagliflozin | ↑ urinary glucose excretion; cardioprotective |
| Insulin | Various | Direct glucose lowering for advanced disease |
Key points:
- Metformin is the universal first-line agent — cheap, effective, safe
- ~50% of patients need a second drug within 3 years
- GLP-1 agonists and SGLT-2 inhibitors now preferred as add-ons due to cardiovascular/renal benefits (ROSEN's Emergency Medicine; Henry's Clinical Diagnosis & Management)
3. 🫁 Asthma
Pathophysiology: Chronic airway inflammation + bronchospasm.
Treatment (Stepwise GINA Approach):
| Severity | Treatment |
|---|---|
| Mild intermittent | Short-acting β₂ agonist (SABA) PRN — e.g., salbutamol (albuterol) |
| Mild persistent | Low-dose inhaled corticosteroid (ICS) — e.g., budesonide |
| Moderate persistent | ICS + Long-acting β₂ agonist (LABA) — e.g., budesonide/formoterol |
| Severe persistent | High-dose ICS + LABA ± systemic corticosteroids |
| Refractory/eosinophilic | Biologic therapy — e.g., omalizumab (anti-IgE), mepolizumab (anti-IL-5) |
Acute attack: SABA nebulization + systemic corticosteroids + oxygen
(Katzung's Basic & Clinical Pharmacology, 16th Ed.; Murray & Nadel's Respiratory Medicine)
4. 🫁 Pneumonia (Community-Acquired)
Empiric Treatment by Setting:
| Setting | Preferred Treatment |
|---|---|
| Outpatient, healthy | Amoxicillin OR azithromycin/doxycycline (atypicals) |
| Outpatient, comorbidities | Amoxicillin-clavulanate + macrolide OR respiratory fluoroquinolone (levofloxacin) |
| Hospitalized, non-ICU | β-lactam + macrolide OR fluoroquinolone |
| ICU | Anti-pseudomonal β-lactam + macrolide + fluoroquinolone |
| PCP (immunocompromised) | TMP-SMX (co-trimoxazole) — high-dose, 3 weeks |
(Washington Manual of Medical Therapeutics; Goldman-Cecil Medicine)
5. ❤️ Heart Failure (HFrEF — Reduced Ejection Fraction)
Four Pillars of Modern HFrEF Therapy ("Fantastic Four"):
| Drug Class | Example | Benefit |
|---|---|---|
| ACE inhibitor / ARB / ARNI | Sacubitril/valsartan (ARNI preferred) | Reduces mortality & hospitalizations |
| β-blocker | Carvedilol, Bisoprolol, Metoprolol succinate | Reduces mortality |
| Mineralocorticoid antagonist | Spironolactone, Eplerenone | Reduces mortality |
| SGLT-2 inhibitor | Dapagliflozin, Empagliflozin | Reduces HF hospitalizations & mortality |
Diuretics (furosemide/bumetanide) for symptom relief (fluid overload) but no mortality benefit.
Device therapy: ICD for sudden cardiac death prevention; CRT for wide QRS + reduced EF.
(Braunwald's Heart Disease, 2-Volume Set)
6. 🧠 Depression (Major Depressive Disorder)
Treatment approach:
| Modality | Details |
|---|---|
| First-line pharmacotherapy | SSRIs — Fluoxetine, Sertraline, Escitalopram (best tolerated) |
| Second-line | SNRIs — Venlafaxine, Duloxetine |
| Alternative | Bupropion (also for smoking cessation), Mirtazapine |
| Treatment-resistant | Augmentation with lithium, atypical antipsychotics (aripiprazole, quetiapine), or ketamine/esketamine |
| Psychotherapy | Cognitive Behavioral Therapy (CBT) — equally effective as medication for mild-moderate depression |
| Severe/refractory | Electroconvulsive Therapy (ECT) — most effective treatment overall |
(Kaplan & Sadock's Comprehensive Textbook of Psychiatry)
7. 🦠 Upper Respiratory Tract Infection (Common Cold / Influenza)
| Condition | Treatment |
|---|---|
| Common cold (viral) | Supportive: rest, fluids, paracetamol/ibuprofen for fever |
| Influenza | Oseltamivir (Tamiflu) — start within 48 hrs of symptoms; reduces duration |
| Strep throat (bacterial) | Amoxicillin × 10 days (first-line); penicillin V alternative |
8. 🦴 Osteoarthritis
| Treatment Step | Options |
|---|---|
| Non-pharmacological | Weight loss, physiotherapy, exercise |
| Topical | Diclofenac gel, topical capsaicin |
| Oral | Paracetamol (acetaminophen); NSAIDs (ibuprofen, naproxen) |
| Intra-articular | Corticosteroid injections for acute flares |
| Surgical | Joint replacement (knee/hip) for end-stage disease |
Quick Reference Summary
| Disease | First-Line Treatment |
|---|---|
| Hypertension | ACE inhibitor/ARB + CCB ± thiazide |
| Type 2 Diabetes | Metformin → add GLP-1 or SGLT-2 |
| Asthma | SABA PRN → ICS → ICS+LABA |
| Pneumonia (CAP) | Amoxicillin or fluoroquinolone |
| Heart Failure (HFrEF) | ARNI + β-blocker + MRA + SGLT-2i |
| Depression | SSRI (sertraline/escitalopram) + CBT |
| Influenza | Oseltamivir within 48 hours |
| Osteoarthritis | Weight loss + paracetamol/NSAIDs |
Note: All treatment decisions must be individualized based on patient comorbidities, allergies, organ function, and clinical context. Always consult current local guidelines and a licensed clinician before prescribing.
Explain
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I have all the information needed. Here is a complete explanation of this prescription:
Prescription Explanation — Kamal Khan, 75yr Male (18/5/26)
Prescribing Doctor: Dr. Deepika Bansal, MBBS, M.D. (Psychiatry) — This is a psychiatric prescription from a specialist.
Rx Notation Decoded
| Symbol | Meaning |
|---|---|
| Ⓡ | Recipe (Latin) — "take" — standard prescription symbol |
| Tab. | Tablet |
| OD | Once Daily |
| HS | Hour of Sleep = at bedtime |
| ①-x-x | 1 tablet in the morning, none at noon, none at night |
| x-x-① | None in morning, none at noon, 1 tablet at bedtime |
| Aux 5 days | Follow-up in 5 days |
Medicine 1: Tab. NEXITO 5 mg — OD (①-x-x)
Generic name: Escitalopram 5 mg
Class: SSRI (Selective Serotonin Reuptake Inhibitor) — Antidepressant
What it does:
- Blocks the reuptake of serotonin in the brain, increasing its availability
- Used for depression, generalized anxiety disorder, panic disorder
- One of the best-tolerated SSRIs — escitalopram causes less anxiety/insomnia than fluoxetine
Why prescribed: For this 75-year-old, the low dose (5 mg) is appropriate — elderly patients are started at half the usual adult dose due to slower drug metabolism
How to take: 1 tablet every morning
Common side effects: Initial mild nausea, insomnia (hence taken in morning), emotional blunting with long-term use — Kaplan & Sadock's Comprehensive Textbook of Psychiatry
Medicine 2: Tab. SIZODON 0.5 mg — HS (x-x-①)
Generic name: Risperidone 0.5 mg
Class: Atypical (Second-Generation) Antipsychotic
What it does:
- Blocks dopamine D₂ and serotonin 5-HT₂A receptors simultaneously
- Used for: psychosis, agitation, behavioural disturbances, sleep problems, anxiety with psychotic features
- At low doses (0.5 mg) in elderly, commonly used for behavioural and sleep disturbances — not necessarily for frank psychosis
Why prescribed: In a 75-year-old patient, 0.5 mg at bedtime is a standard low-dose for agitation, irritability, or anxiety with perceptual disturbances
How to take: 1 tablet at bedtime
Important caution for elderly: All antipsychotics carry a black-box warning for increased mortality in elderly dementia patients. Doctor has chosen the lowest possible dose — Goodman & Gilman's Pharmacological Basis of Therapeutics; Kaplan & Sadock's
Medicine 3: Tab. PETRIL 0.25 mg — HS (x-x-①)
Generic name: Clonazepam 0.25 mg
Class: Benzodiazepine — Anxiolytic / Sedative-Hypnotic
What it does:
- Enhances GABA (inhibitory neurotransmitter) activity in the brain → calms the nervous system
- Used for: anxiety, insomnia, panic attacks, restlessness
- Provides sleep onset and reduces nocturnal awakenings
Why prescribed: Very low dose (0.25 mg) at bedtime for this elderly patient — helps with sleep and nighttime anxiety/restlessness
How to take: 1 tablet at bedtime
Cautions: Benzodiazepines can cause daytime drowsiness, dizziness, falls, and memory problems — risk is higher in elderly. The very low dose minimises these risks — Katzung's Basic & Clinical Pharmacology, 16th Ed.
Overall Picture
This prescription is a standard low-dose psychiatric regimen for an elderly patient, most likely for:
Anxiety with depression and/or agitation/sleep disturbance — possibly in the context of late-life anxiety, mild psychosis, or behavioural issues
| # | Medicine | Class | Timing | Purpose |
|---|---|---|---|---|
| 1 | Nexito 5 mg (Escitalopram) | SSRI | Morning | Depression/anxiety |
| 2 | Sizodon 0.5 mg (Risperidone) | Antipsychotic | Bedtime | Agitation/behavioural control |
| 3 | Petril 0.25 mg (Clonazepam) | Benzodiazepine | Bedtime | Sleep/anxiety relief |
⚠️ All three doses are intentionally very low — this is standard practice for elderly patients (75 years old) since their bodies process medicines more slowly. Follow up with Dr. Deepika Bansal in 5 days as instructed. Do not adjust or stop any medicine without consulting the doctor.
This is a shared conversation. Sign in to Orris to start your own chat.